Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder

Completed · Phase 3 · Has a placebo group

Conditions studied: Binge Eating Disorder

In brief

The specific aim of this study is to examine the efficacy and safety of lisdexamfetamine compared with placebo in outpatients with binge eating disorder

Key facts

Study ID

NCT01090713

Run by

Lindner Center of HOPE

People needed

50

Starts

2010-01-01

Expected to finish

2012-10-01

Last updated by the study team

2016-07-15

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients will meet DSM-IV criteria for BED for at least the last 6 months

You may not qualify if…

• Women who are pregnant or lactating and women of childbearing potential who are not taking adequate contraceptive measures. If there is a possibility a female subject might be pregnant, a pregnancy test will be performed. (All women of childbearing potential will have a negative pregnancy test before entering the study.)
• Subjects who are displaying clinically significant suicidality or homicidality.
• A current or recent (within 6 months of the start of study medication) DSM-IV diagnosis of substance abuse or dependence

Where it is running

• Lindner Center of HOPE — Mason, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.